Search | Page 22 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia

    ... or acute myeloid leukemia. Drugs used in chemotherapy , such as liposomal cytarabine-daunorubicin CPX-351, work in ...

    Clinical Trial last updated 04/28/2016 - 10:05am.

  2. Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia

    ... (identical vs other). Cytoreductive combination chemotherapy : Patients receive busulfan intravenously (IV) over 2 hours ...

    Clinical Trial last updated 04/28/2016 - 8:49am.

  3. A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML)

    ... conditions that compromise the ability to give cytotoxic chemotherapy as the primary modality. Patients who decline cytotoxic chemotherapy. Patients with AML of age ≥ 60 years who have relapsed ...

    Clinical Trial last updated 06/03/2016 - 3:09pm.

  4. A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

    ... [ITP], liver disease, aplastic anemia and chemotherapy induced thrombocytopenia). Approximately 350 subjects will be ...

    Clinical Trial last updated 04/27/2016 - 1:28pm.

  5. Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

    ... leukemia, or myelodysplastic syndromes. Giving chemotherapy and total-body irradiation before a donor umbilical cord blood ...

    Clinical Trial last updated 04/27/2016 - 1:17pm.

  6. Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm

    ... the body, or myeloproliferative neoplasm. Drugs used in chemotherapy , such as decitabine and cytarabine, work in different ways to ...

    Clinical Trial last updated 04/21/2016 - 1:23pm.

  7. Diagnosis

    ... you been exposed to harmful chemicals? Did you have chemotherapy or radiation treatments in the past? Is your urine dark or ...

    Topic section last updated 04/19/2016 - 3:35pm.

  8. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... study b.         Eligible to receive induction chemotherapy , such as 7-10 days of cytosine arabinoside and 2-3 days of an ... Any other concurrent investigational agent or chemotherapy, radiotherapy, or immunotherapy, or corticosteroids ( ...

    Clinical Trial last updated 11/29/2016 - 8:29am.

  9. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... standard transplant therapy with either high doses of chemotherapy drugs or lower doses of chemotherapy drugs, depending on their disease. Diseases within each disease ...

    Clinical Trial last updated 04/27/2016 - 8:55am.

  10. Cyclophosphamide

    ... known as cytophosphane, is a medication mainly used in chemotherapy . It is an alkylating agent of the nitrogen mustard type ...

    Drug last updated 03/24/2016 - 12:32pm.